A groundbreaking advancement in tumor immunotherapy is unfolding with the approval of a new mRNA vaccine for Epstein-Barr virus (EBV) positive tumors by China's National Medical Products Administration (NMPA) for Phase-I clinical trials. Developed independently by WestGene Biopharma Co., Ltd.,
Pfizer Inc. has unveiled a significant advancement in their ongoing Phase 3 MONeT trial, specifically through a substudy aiming to evaluate the efficacy and safety of its RSV vaccine, ABRYSVO, in immunocompromised adults. Historically, this vulnerable population has faced severe complications from
The pharmaceutical industry is undergoing a significant transformation driven by the integration of data analytics, reshaping various aspects such as drug discovery, clinical trials, supply chain management, and commercial strategies. This change is not just a trend but a necessity as the industry
The pharmaceutical industry is undergoing a significant transformation driven by the advent of pharma analytics. Utilizing modern data analytics tools has revolutionized various stages of drug development, manufacturing, and distribution. This article explores how these advancements are shaping the
The U.S. Food and Drug Administration (FDA) has ushered in a new era in cancer treatment with the approval of Tecelra (afamitresgene autoleucel), an innovative therapy aimed at combating synovial sarcoma. This rare and aggressive form of cancer predominantly impacts young adults and has
The biotech landscape is abuzz with the launch of Red Queen Therapeutics, a startup that aims to revolutionize antiviral treatments. Backed by a $55 million investment from venture firm Apple Tree Partners and additional funding from the Biomedical Advanced Research and Development Authority